Pfizer Vaccine on Track for Regulatory Review



    Name*
    Email*
    Message

    WhatsApp Top Page Banner

    Pfizer Vaccine on Track for Regulatory Review

    Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from an early-stage study • Full Story

    News Max

    Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from an early-stage study.

    The companies said the vaccine was well tolerated with mild to moderate fever in fewer than 20% of the participants. The companies are continuing to analyze data from the Phase 1 trials in the U.S. and Germany, they said in a statement.

    The timeline would make the vaccine one of the fastest-moving in the world. Some analysts expect a vaccine to be approved for use by November in the U.S., a move which may give President Donald Trump a new foothold in the election.

    48

    Tags: , ,

    Add Comment

    *Only proper comments will be allowed

    Related Posts:

    Pfizer Vaccine on Track for Regulatory Review



      Name*
      Email*
      Message